Orthopedic biomaterial company Graftys SA said it launched a post market surveillance patient registry examining recipients of its HBS and Quickset phosphocalcic cements. The goal of the study is to systematically validate previous short and long term clinical results of the cements, the French orthopedic company said. “It is important to be able to follow our […]